Feike Sijbesma - Koninklijke DSM Chairman of the Managing Board and CEO

KDSKF Stock  USD 43.02  65.78  60.46%   

Chairman

Mr. Feike Sijbesma has served as Chief Executive Officer and Chairman of the Managing Board of Royal DSM NV, since May 1, 2007. He was first appointed as Member of the Managing Board in July 2000. In 1987, he joined the Industrial Pharmaceuticals division of Gistbrocades, where he was responsible for strategic planning and business development. From 1990 to 1993, he was appointed the division Marketing and Sales Director. Thereafter he was given leadership of Savoury Ingredients and later on a business unit of Gistbrocades Food Specialties Division. In 1995, he was made Director of that division and joined the Gistbrocades Executive Committee. Following the acquisition by DSM in 1998 he became Director of the business group DSM Food Specialties. In 2000, Mr. Sijbesma joined DSM Managing Board of Directors. In addition to this, Mr. Sijbesma also serves as Nonexecutive Director of Unilever Member of the Supervisory Board of Dutch Central Bank Member of Global CEO Council Chinese People Association for Friendship with Foreign Countries Climate leader for the World Bank Group CoChair of the High Level Assembly of the Carbon Pricing Leadership Coalition, convened by the World Bank. since 2007.
Age 58
Tenure 17 years
Professional MarksCPA
Phone31 45 578 8111
Webhttps://www.dsm.com

Koninklijke DSM Management Efficiency

The company has return on total asset (ROA) of 0.0402 % which means that it generated a profit of $0.0402 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1189 %, meaning that it generated $0.1189 on every $100 dollars invested by stockholders. Koninklijke DSM's management efficiency ratios could be used to measure how well Koninklijke DSM manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.84 B in total debt with debt to equity ratio (D/E) of 0.31, which is about average as compared to similar companies. Koninklijke DSM NV has a current ratio of 2.46, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Koninklijke DSM until it has trouble settling it off, either with new capital or with free cash flow. So, Koninklijke DSM's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Koninklijke DSM NV sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Koninklijke to invest in growth at high rates of return. When we think about Koninklijke DSM's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 10 records

CHAIRMAN Age

Douglas BakerEcolab Inc
62
Benoit PotierAir Liquide SA
59
John MorikisSherwin Williams Co
61
Edward BreenDupont De Nemours
68
Edgar SiaDupont De Nemours
N/A
Christopher ConnorSherwin Williams Co
58
Charles BunchPPG Industries
65
Douglas FordAir Products and
69
Seifollah GhasemiAir Products and
80
Tony CaktiongDupont De Nemours
64
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands. KONINKLIJKE DSM operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 21760 people. Koninklijke DSM NV [KDSKF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Koninklijke DSM NV Leadership Team

Elected by the shareholders, the Koninklijke DSM's board of directors comprises two types of representatives: Koninklijke DSM inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Koninklijke. The board's role is to monitor Koninklijke DSM's management team and ensure that shareholders' interests are well served. Koninklijke DSM's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Koninklijke DSM's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Routs, Chairman of the Supervisory Board
Eileen Kennedy, Member of the Supervisory Board
Ewald Kist, Deputy Chairman of the Supervisory Board
Frits Paasschen, Independent Member of the Supervisory Board
John Ramsay, Independent Member of the Supervisory Board
Stefan Doboczky, Member of the Managing Board
Paul Gilgen, Head Products
Lieke JongTops, Communications Mang
Stephan Tanda, Member of the Managing Board
Geraldine Matchett, CFO and Member of the Managing Board
Luca Rosetto, VP Products
Dimitri Vreeze, Member of the Managing Board
Dave Huizing, Vice President Investor Relations
Rob Atsma, Head Nederland
Pauline Mohr, Member of the Supervisory Board
Victoria Haynes, Member of the Supervisory Board
Jan Wolters, Head Chemicals
Bruno Mller, Head Products
Pradeep Pant, Member of the Supervisory Board
Manfred Eggersdorfer, VP Advocacy
Feike Sijbesma, Chairman of the Managing Board and CEO
Pierre Hochuli, Member of the Supervisory Board
Tom Swaan, Member of the Supervisory Board

Koninklijke Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Koninklijke DSM a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Koninklijke DSM in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Koninklijke DSM's short interest history, or implied volatility extrapolated from Koninklijke DSM options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Koninklijke DSM NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Koninklijke Pink Sheet analysis

When running Koninklijke DSM's price analysis, check to measure Koninklijke DSM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Koninklijke DSM is operating at the current time. Most of Koninklijke DSM's value examination focuses on studying past and present price action to predict the probability of Koninklijke DSM's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Koninklijke DSM's price. Additionally, you may evaluate how the addition of Koninklijke DSM to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Please note, there is a significant difference between Koninklijke DSM's value and its price as these two are different measures arrived at by different means. Investors typically determine if Koninklijke DSM is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Koninklijke DSM's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.